Roger J. Pomerantz
Chairman
Indaptus Therapeutics, Inc. (INDP)Board Member
Indaptus Therapeutics, Inc. (INDP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roger J. Pomerantz
Roger J. Pomerantz is recorded as Chairman and Board Member at Indaptus Therapeutics, Inc. (INDP). Indaptus Therapeutics, Inc. reported in an 8-K filed March 24, 2026 that Roger J. Pomerantz resigned as Director, effective March 18, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed June 7, 2024 that Roger J. Pomerantz was appointed Class III director, effective June 6, 2024.
“Jeffrey A. Meckler, Roger J. Pomerantz, Anthony J. Maddaluna, and William B. Hayes (together, the "Resigning Directors") resigned on March 18, 2026.”
“Based on the foregoing votes, Roger J. Pomerantz, Michael J. Newman and Jeffrey A. Meckler were elected as Class III directors, and Proposals 2 and 3 were approved.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-06–present
-
Current
Start not stated–present
-
2024-06-06–2026-03-18
-
2021-01-01–2026-03-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Indaptus Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David E. Lazar CEO, Chairman
- David Lazar CEO, Chairman, Board Member
- Jeffrey A. Meckler CEO, Board Member
- Jeffrey Meckler CEO
- Junyi Dai CEO, Chairman, Board Member
- Yu Ding CFO
- Walt A. Linscott COO
- Anthony J. Maddauluna Board Member
- Avraham Ben-Tzvi Board Member
- David Natan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.